Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Promyelocytic Leukemia
100%
Glioblastoma Cells
100%
EGF Receptor
100%
Altered Expression
100%
Antisense
100%
Epidermal Growth Factor Receptor
83%
Cell Growth
66%
Glioblastoma
33%
Complementary DNA (cDNA)
16%
Growth Response
16%
Transfected Cells
16%
Sigma Phase
16%
G1 Arrest
16%
HEC-RAS
16%
Growth Arrest
16%
Genetic Modification
16%
Cellular Response
16%
Role in Cancer
16%
P53 Protein
16%
Regulatory Programs
16%
Oncogene
16%
P16INK4a
16%
Dot Pattern
16%
Retinoblastoma
16%
Cancer Development
16%
Molecular Genetics
16%
Growth Differentiation
16%
Gene Amplification
16%
Enhanced Expression
16%
Promyelocytic Leukemia Protein
16%
Growth Regulators
16%
Suppressing Cell
16%
Staining Pattern
16%
Cyclin-dependent Kinase 4 (CDK4)
16%
Immunohistochemical Assay
16%
Receptor Function
16%
Signal Transduction Pathway
16%
Cell Cycle Genes
16%
Receptor Cells
16%
Response to Treatment
16%
Carcinogenic Mechanism
16%
Nuclear Dots
16%
Suppressor Protein
16%
Medicine and Dentistry
Glioblastoma
100%
Protein P53
100%
Antisense
100%
Acute Promyelocytic Leukemia
100%
Epidermal Growth Factor Receptor
100%
Cell Growth
66%
Promyelocytic Leukemia Protein
33%
Ras
16%
Malignant Neoplasm
16%
Cell Cycle
16%
S Phase
16%
P16
16%
Growth Disorder
16%
Cyclin-Dependent Kinase 4
16%
Proto Oncogene
16%
G1/S Transition
16%
P21
16%
Retinoblastoma
16%
Gene Amplification
16%
Gene Mutation
16%
Complementary DNA
16%
Biochemistry, Genetics and Molecular Biology
Antisense
100%
P53
100%
Epidermal Growth Factor Receptor
100%
Cell Growth
66%
Promyelocytic Leukemia Protein
33%
Nuclear Dots
16%
Molecular Genetics
16%
Gene Mutation
16%
Cell Cycle
16%
P21
16%
S Phase
16%
Gene Amplification
16%
P16
16%
Proto Oncogene
16%
Retinoblastoma
16%
Cyclin-Dependent Kinase 4
16%
Pharmacology, Toxicology and Pharmaceutical Science
Glioblastoma
100%
Promyelocytic Leukemia
100%
Protein P53
100%
Epidermal Growth Factor Receptor
100%
Promyelocytic Leukemia Protein
33%
Cyclin Dependent Kinase 4
16%
Malignant Neoplasm
16%
Complementary DNA
16%
Growth Disorder
16%
Retinoblastoma
16%
Immunology and Microbiology
Antisense
100%
P53
100%
Epidermal Growth Factor
83%
Cell Growth
66%
Promyelocytic Leukemia Protein
33%
Cycline
16%
Nuclear Dots
16%
Proto Oncogene
16%
Gene Amplification
16%
Gene Mutation
16%
Cell Cycle
16%
Neuroscience
P53
100%
Epidermal Growth Factor Receptor
100%
Cell Growth
66%
Promyelocytic Leukemia Protein
33%
Staining Technique
16%
Complementary DNA
16%
Retinoblastoma
16%
Cell Cycle
16%
Growth Disorder
16%
Proto Oncogene
16%
G1 Phase Cell Cycle Checkpoint
16%
Cyclin Dependent Kinase 4
16%
Gene Amplification
16%
Gene Mutation
16%